Trademark: BIFICOL 1267451
Word
BIFICOL
ID
1267451
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
22 July 2008
Registration Date
22 July 2008
Renewal Date
22 July 2028
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 1:
Micro-organisms and cultures of micro-organisms, in particular bacteria, bifid bacteria, yeast and fermented milk products; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, not for medical or veterinary use; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form
Micro-organisms and cultures of micro-organisms, in particular bacteria, bifid bacteria, yeast and fermented milk products; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, not for medical or veterinary use; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form
Class 5:
Micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; specialty pharmaceuticals containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhoea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, in the form of pharmaceuticals for oral application, in particular capsules, compress, solutions, suspensions, granules, granulates in dried or freeze-dried form, food supplements, food supplements for medical use containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings, not for medical use; symbiotic supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria and prebiotic fibres
Micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; specialty pharmaceuticals containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhoea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, in the form of pharmaceuticals for oral application, in particular capsules, compress, solutions, suspensions, granules, granulates in dried or freeze-dried form, food supplements, food supplements for medical use containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings, not for medical use; symbiotic supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria and prebiotic fibres